Influence of measles vaccination on the progression of atopic dermatitis in infants

Pediatric Allergy and Immunology

Volumn 18, Issue 5, 2007, Pages 385-390

  Hennino, Anà ^a,b,e   Cornu, Catherine ^b   Rozieres, Aurore ^b,c   Augey, Frédéric ^c   Villard Truc, Florence ^d   Payot, François ^d   Lachaux, Alain ^a,d   Nicolas, Jean François ^a,b,c,e   Horvat, Branka ^b,e,f  

^a UNIVERSITÉ LYON 1   (France)

^b INSERM   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

^d EDOUARD HERRIOT HOSPITAL   (France)

^e University Lyon i   (France)

^f UNIVERSITÉ DE LYON   (France)

Author keywords

Atopic dermatitis; CCL18; E selectin; Measles vaccination

Indexed keywords

ATODERM; CHEMOKINE; CHEMOKINE CCL18; DESONIDE; EMOLLIENT AGENT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; MEASLES VACCINE; PLACEBO; PROTEIN PARC; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; ATOPIC DERMATITIS; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; IMMUNOLOGICAL PARAMETERS; INFANT; MALE; MEASLES; MEASLES VACCINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SEROCONVERSION; SINGLE DRUG DOSE;

CHEMOKINES, CC; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; E-SELECTIN; FEMALE; HUMANS; INFANT; MALE; MEASLES; MEASLES VACCINE; PROSPECTIVE STUDIES;

EID: 34447118851     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2007.00537.x     Document Type: Article

References (34)

1. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest 2004 : 113 : 651 7.
2. Santamaria Babi LF, Picker LJ, Perez Soler MT, et al. Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen. J Exp Med 1995 : 181 : 1935 40.
3. Wolkerstorfer A, Savelkoul HF, de Waard van der Spek FB, Neijens HJ, van Meurs T, Oranje AP. Soluble E-selectin and soluble ICAM-1 levels as markers of the activity of atopic dermatitis in children. Pediatr Allergy Immunol 2003 : 14 : 302 6.
4. Yamashita N, Kaneko S, Kouro O, Furue M, Yamamoto S, Sakane T. Soluble E-selectin as a marker of disease activity in atopic dermatitis. J Allergy Clin Immunol 1997 : 99 : 410 6.
5. Gunther C, Bello-Fernandez C, Kopp T, et al. CCL18 is expressed in atopic dermatitis and mediates skin homing of human memory T cells. J Immunol 2005 : 174 : 1723 8.
6. Nomura I, Gao B, Boguniewicz M, Darst MA, Travers JB, Leung DY. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 2003 : 112 : 1195 202.
7. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997 : 349 : 1269 76.
8. Jansen VA, Stollenwerk N, Jensen HJ, Ramsay ME, Edmunds WJ, Rhodes CJ. Measles outbreaks in a population with declining vaccine uptake. Science 2003 : 301 : 804.
9. Olesen AB, Juul S, Thestrup-Pedersen K. Atopic dermatitis is increased following vaccination for measles, mumps and rubella or measles infection. Acta Derm Venereol 2003 : 83 : 445 50.
10. Paunio M, Heinonen OP, Virtanen M, Leinikki P, Patja A, Peltola H. Measles history and atopic diseases: a population-based cross-sectional study. Jama 2000 : 283 : 343 6.
11. Bodner C, Anderson WJ, Reid TS, Godden DJ. Childhood exposure to infection and risk of adult onset wheeze and atopy. Thorax 2000 : 55 : 383 7.
12. Roost HP, Gassner M, Grize L, et al. Influence of MMR-vaccinations and diseases on atopic sensitization and allergic symptoms in Swiss schoolchildren. Pediatr Allergy Immunol 2004 : 15 : 401 7.
13. Shaheen SO, Aaby P, Hall AJ, et al. Measles and atopy in Guinea-Bissau. Lancet 1996 : 347 : 1792 6.
14. Boner AL, Valletta EA, Bellanti JA. Improvement of atopic dermatitis following natural measles virus infection. Four case reports. Ann Allergy 1985 : 55 : 605 8.
15. Kondo N, Fukutomi O, Ozawa T, et al. Improvement of food-sensitive atopic dermatitis accompanied by reduced lymphocyte responses to food antigen following natural measles virus infection. Clin Exp Allergy 1993 : 23 : 44 50.
16. Hanifin J, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980 : 92 (Suppl.144 44 7.
17. Kunz B, Oranje A, Labreze L, Stalder J, Ring J, Taieb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997 : 195 : 10 9.
18. Dalton SJ, Haeney MR, Patel L, David TJ. Exacerbation of atopic dermatitis after Bacillus Calmette-Guerin vaccination. J R Soc Med 1998 : 91 : 133 4.
19. Engler RJ, Kenner J, Leung DY. Smallpox vaccination: risk considerations for patients with atopic dermatitis. J Allergy Clin Immunol 2002 : 110 : 357 65.
20. Tamashiro VG, Perez HH, Griffin DE. Prospective study of the magnitude and duration of changes in tuberculin reactivity during uncomplicated and complicated measles. Pediatr Infect Dis J 1987 : 6 : 451 4.
21. Hirsch RL, Griffin DE, Johnson RT, et al. Cellular immune responses during complicated and uncomplicated measles virus infections of man. Clin Immunol Immunopathol 1984 : 31 : 1 12.
22. Fireman P, Friday G, Kumate J. Effect of measles vaccine on immunologic responsiveness. Pediatrics 1969 : 43 : 264 72.
23. Hussey GD, Goddard EA, Hughes J, et al. The effect of Edmonston-Zagreb and Schwarz measles vaccines on immune response in infants. J Infect Dis 1996 : 173 : 1320 6.
24. Pabst HF, Spady DW, Carson MM, Stelfox HT, Beeler JA, Krezolek MP. Kinetics of immunologic responses after primary MMR vaccination. Vaccine 1997 : 15 : 10 4.
25. Ito M, Watanabe M, Kamiya H, Sakurai M. Changes in intracellular cytokine levels in lymphocytes induced by measles virus. Clin Immunol Immunopathol 1997 : 83 : 281 6.
26. Marie JC, Astier AL, Rivailler P, Rabourdin-Combe C, Wild TF, Horvat B. Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nature Immunol 2002 : 3 : 659 66.
27. Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003 : 421 : 388 92.
28. Ou LS, Goleva E, Hall C, Leung DY. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol 2004 : 113 : 756 63.
29. Carballido JM, Aversa G, Kaltoft K, et al. Reversal of human allergic T helper 2 responses by engagement of signaling lymphocytic activation molecule. J Immunol 1997 : 159 : 4316 21.
30. Arkwright PD, David TJ. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J Allergy Clin Immunol 2001 : 107 : 531 4.
31. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 1997 : 275 : 77 9.
32. Martignon G, Oryszczyn MP, Annesi-Maesano I. Does childhood immunization against infectious diseases protect from the development of atopic disease? Pediatr Allergy Immunol 2005 : 16 : 193 200.
33. Gruber C, Meinlschmidt G, Bergmann R, Wahn U, Stark K. Is early BCG vaccination associated with less atopic disease? An epidemiological study in German preschool children with different ethnic backgrounds. Pediatr Allergy Immunol 2002 : 13 : 177 81.
34. Hirsch RL, Mokhtarian F, Griffin DE, Brooks BR, Hess J, Johnson RT. Measles virus vaccination of measles seropositive individuals suppresses. Clin Immunol Immunopathol 1981 : 21 : 341 50.